Talis Biomedical Corporation TLIS
Set alert
2.84 USD +2.84 —
Day range unavailable
52-week range unavailable
- YTD
- 0.00%
- 1 year
- +71.08%
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 3.23M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.08
- Beta
- 1.56
- Short ratio
- 0.59
- Inst. own
- 55.06%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 24, 2024
- 50-d avg
- 1.89
- 200-d avg
- 6.59
- 1y target
- 0.00
6M chart
Signals (7)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jan 9, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 18, 2025 | 10 months ago |
| RSI: Overbought | Dec 18, 2025 | 10 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 21, 2025 | 1 year ago |
| RSI: Overbought | Oct 21, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 7, 2025 | 1 year ago |
Key statistics
- Market cap
- 3.23M
- Enterprise value
- -37.76M
- Trailing P/E
- 0.00
- Forward P/E
- -0.08
- PEG ratio
- 0.00
- Price / sales
- 7.91
- Price / book
- 0.07
- EPS (TTM)
- -28.02
- Beta
- 1.56
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 408.00K
- Revenue growth
- 0.00%
- Free cash flow
- -25.91M
- Total cash
- 59.87M
- Total debt
- 18.80M
- Return on equity
- -70.48%
- Shares outstanding
- 1.82M
- Short % of float
- 1.54%
- 50-day average
- 1.89
- 200-day average
- 6.59
Analyst view
Consensus: sell
Sell
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 0 hold · 1 sell
- Strong buy0
- Buy0
- Hold0
- Sell0
- Strong sell1
Next earnings
Dec 24, 2024
Expected Dec 24, 2024. Consensus EPS estimate 0.00.
Financials — quick view
TLIS Revenue — quarterly 0
TLIS Net income — quarterly -8.85M
TLIS EPS — quarterly -4.86
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 24, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -4.86 | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.00 | -7.15 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | -7.39 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -8.62 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -8.27 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 15, 2023 | BTIG | main | Sell | Sell |
About Talis Biomedical Corporation
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- talisbio.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on TLIS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| LEONARD BRADEN MICHAEL | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 5, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Greenlight Capital, Inc. | 8.19% | 149,053 | 71.55K | Jun 29, 2023 |
| Vanguard Group Inc | 1.71% | 31,090 | 14.92K | Jun 29, 2023 |
| Tudor Investment Corporation | 0.55% | 10,000 | 4.80K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.52% | 9,369 | 4.50K | Jun 29, 2023 |
| Millennium Management Llc | 0.34% | 6,098 | 2.93K | Jun 29, 2023 |
| Blackrock Inc. | 0.28% | 5,087 | 2.44K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.00% | 18,267 | 8.77K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.68% | 12,452 | 5.98K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.29% | 5,205 | 2.55K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.11% | 1,953 | 957 | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.05% | 905 | 443 | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.05% | 978 | 479 | May 30, 2023 |